Skip to main content

Arch Biopartners Inc(ARCH-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Arch Biopartners Inc down on Wednesday (ARCH)

AI-generated - The Globe and Mail - Wed Dec 6, 2023

In trading today, shares of Arch Biopartners Inc opened at $1.50 and closed at $1.51. prices ranged from $1.50 to $1.51.

The price eased -0.66 percent from the previous day's close of $1.52.

Today across North America, the TSX Composite closed -0.17% at 20375.93, the S&P 500 closed -0.06% at 4567.18, the Dow Jones Industrial Average closed -0.22% at 36124.56 and the Nasdaq Composite closed 0.31% at 14229.91.

Arch Biopartners Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker ARCH.

Trading volume was 3,810 on 10 total trades, with an average volume of 56,157 over 5 days.

Trading across the entire TSX-V saw 3,021 price advancers against 2,185 declines and 119 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $3.03 (January 16,2023) and low as $0.97 (November 03,2023). Moreover, the shares have reduced -49.15 percent in the last 52 weeks, while they have shrunken -46.62% this year.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $95.15 million on a float of 62,599 shares outstanding. Its annual EPS is $-0.06.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Based on 0.00 analysts, Arch Biopartners Inc gets an average recommendation of "Strong Sell" according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..